The DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
Mesoporous Silica Nanoparticles: A Comprehensive Review on Synthesis and Recent Advances
Open accessAbstract
Recent advancements in drug delivery technologies utilizing a variety of carriers have resulted in a path-breaking revolution in the approach towards diagnosis and therapy alike in the current times. Need for materials with high thermal, chemical and mechanical properties have led to the development of mesoporous silica nanoparticles (MSNs). These ordered porous materials have garnered immense attention as drug carriers owing to their distinctive features over the others. They can be synthesized using a relatively simple process, thus making it cost effective. Moreover, by controlling the parameters during the synthesis; the morphology, pore size and volume and particle size can be transformed accordingly. Over the last few years, a rapid increase in research on MSNs as drug carriers for the treatment of various diseases has been observed indicating its potential benefits in drug delivery. Their widespread application for the loading of small molecules as well as macromolecules such as proteins, siRNA and so forth, has made it a versatile carrier. In the recent times, researchers have sorted to several modifications in the framework of MSNs to explore its potential in drug resistant chemotherapy, antimicrobial therapy. In this review, we have discussed the synthesis of these multitalented nanoparticles and the factors influencing the size and morphology of this wonder carrier. The second part of this review emphasizes on the applications and the advances made in the MSNs to broaden the spectrum of its use especially in the field of biomedicine. We have also touched upon the lacunae in the thorough understanding of its interaction with a biological system which poses a major hurdle in the passage of this carrier to the clinical level. In the final part of this review, we have discussed some of the major patents filed in the field of MSNs for therapeutic purpose.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlled growth of monodisperse silica spheres in the micron size range
Stöber, W., Fink, A., & Bohn, E. (1968) · Journal of Colloid and Interface Science · doi:10.1016/0021-9797(68)90272-5 · Cited by 14,532
A new family of mesoporous molecular sieves prepared with liquid crystal templates
Beck, J. S., Vartuli, J. C., Roth, W. J., Leonowicz, M. E., Kresge, C. T., Schmitt, K. D., Chu, C. T. W., Olson, D. H., Sheppard, E. W., McCullen, S. B., et al. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00053a020 · Cited by 10,967
Zhao, D., Huo, Q., Feng, J., Chmelka, B. F., & Stucky, G. D. (1998) · Journal of the American Chemical Society · doi:10.1021/ja974025i · Cited by 6,697
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792 · cited 1×
“AmBisome® Liposome Amphotericin B Antifungal [13] DaunoXome® Liposome Daunorubicin Kaposi’s sarcoma associated with HIV [14] Doxil® Liposome Doxorubicin Kaposi’s sarcoma associated with HIV, breast cancer, ovarian cancer [15]”
BackgroundNanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Hollow Micro‐/Nanostructures: Synthesis and Applications
Lou, X. W. (., Archer, L. A., & Yang, Z. (2008) · Advanced Materials · doi:10.1002/adma.200800854 · Cited by 2,992
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
Tang, F., Li, L., & Chen, D. (2012) · Advanced Materials · doi:10.1002/adma.201104763 · Cited by 2,836
Mesoporous Materials for Drug Delivery
Vallet‐Regí, M., Balas, F., & Arcos, D. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200604488 · Cited by 2,507
Liposomes as nanomedical devices
Bozzuto, G., & Molinari, A. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s68861 · Cited by 2,261
A New Property of MCM-41: Drug Delivery System
Vallet-Regi, M., Rámila, A., del Real, R. P., & Pérez-Pariente, J. (2001) · Chemistry of Materials · doi:10.1021/cm0011559 · Cited by 2,182
Cited by
Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?
Vallet-Regí, M., Schüth, F., Lozano, D., Colilla, M., & Manzano, M. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00659b · Cited by 507
Advances in Antimicrobial Microneedle Patches for Combating Infections
Jamaledin, R., Yiu, C. K. Y., Zare, E. N., Niu, L., Vecchione, R., Chen, G., Gu, Z., Tay, F. R., & Makvandi, P. (2020) · Advanced Materials · doi:10.1002/adma.202002129 · Cited by 461
Multifaceted Application of Silica Nanoparticles. A Review
Jeelani, P. G., Mulay, P., Venkat, R., & Ramalingam, C. (2020) · Silicon · doi:10.1007/s12633-019-00229-y · Cited by 449
Multifunctional mesoporous silica nanoparticles for biomedical applications
Xu, B., Li, S., Shi, R., & Liu, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01654-7 · Cited by 433
Synthesis and applications of anisotropic nanoparticles with precisely defined dimensions
Pearce, A. K., Wilks, T. R., Arno, M. C., & O’Reilly, R. K. (2020) · Nature Reviews Chemistry · doi:10.1038/s41570-020-00232-7 · Cited by 389
Photoluminescent Nanoparticles for Chemical and Biological Analysis and Imaging
Algar, W. R., Massey, M., Rees, K., Higgins, R., Krause, K. D., Darwish, G. H., Peveler, W. J., Xiao, Z., Tsai, H.-Y., Gupta, R., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01176 · Cited by 356
Silica nanoparticles: Biomedical applications and toxicity
Huang, Y., Li, P., Zhao, R., Zhao, L., Liu, J., Peng, S., Fu, X., Wang, X., Luo, R., Wang, R., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113053 · Cited by 356
Nanoparticles in cancer theragnostic and drug delivery: A comprehensive review
Al-Thani, A. N., Jan, A. G., Abbas, M., Geetha, M., & Sadasivuni, K. K. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122899 · Cited by 323
Li, Z., Zhang, Y., & Feng, N. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1575806 · Cited by 321
Role of Silica Nanoparticles in Abiotic and Biotic Stress Tolerance in Plants: A Review
Wang, L., Ning, C., Pan, T., & Cai, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23041947 · Cited by 272
Mane, P. V., Rego, R. M., Yap, P. L., Losic, D., & Kurkuri, M. D. (2024) · Progress in Materials Science · doi:10.1016/j.pmatsci.2024.101314 · Cited by 271
Sol–Gel‐Based Advanced Porous Silica Materials for Biomedical Applications
Lei, Q., Guo, J., Noureddine, A., Wang, A., Wuttke, S., Brinker, C. J., & Zhu, W. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909539 · Cited by 254
Engineered strategies to enhance tumor penetration of drug-loaded nanoparticles
Souri, M., Soltani, M., Moradi Kashkooli, F., & Kiani Shahvandi, M. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.024 · Cited by 178
Aborode, A. T., Pustake, M., Awuah, W. A., Alwerdani, M., Shah, P., Yarlagadda, R., Ahmad, S., Silva Correia, I. F., Chandra, A., Nansubuga, E. P., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7934442 · Cited by 124
Narayan, R., Gadag, S., Cheruku, S. P., Raichur, A. M., Day, C. M., Garg, S., Manandhar, S., Pai, K. S. R., Suresh, A., Mehta, C. H., et al. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.117893 · Cited by 103
Self-citationClinical therapies and nano drug delivery systems for urinary bladder cancer
Jain, P., Kathuria, H., & Momin, M. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107871 · Cited by 89
A review on the applicability of adsorption techniques for remediation of recalcitrant pesticides
Bose, S., Senthil Kumar, P., Rangasamy, G., Prasannamedha, G., & Kanmani, S. (2023) · Chemosphere · doi:10.1016/j.chemosphere.2022.137481 · Cited by 72
Detection of individual insulating entities by electrochemical blocking
Deng, Z., & Renault, C. (2021) · Current Opinion in Electrochemistry · doi:10.1016/j.coelec.2020.08.001 · Cited by 31
Feng, H., Zhang, G., Zhang, S., Han, L., Yuan, Z., Yu, X., Lou, S., Ji, Y., Shafiq, M., EL-Newehy, M., et al. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.172113 · Cited by 5
Metadata
- Authors
- Narayan, R., Nayak, U. Y., Raichur, A. M., & Garg, S.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2018-08-06
- Volume
- 10
- Issue
- 3
- Pages
- 118
- ISSN
- 1999-4923 (ISSN-L)
- OpenAlex
- W2885814196
- Cited by
- 942
- References
- 221
- FWCI
- 30.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.